Natixis cut its position in Baidu, Inc. (NASDAQ:BIDU – Free Report) by 70.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 589 shares of the information services provider’s stock after selling 1,438 shares during the quarter. Natixis’ holdings in Baidu were worth $81,000 at […]

Natixis grew its stake in shares of News Co. (NASDAQ:NWS – Free Report) by 80.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,846 shares of the company’s stock after buying an additional 3,053 shares during the period. Natixis’ holdings in […]

Natixis acquired a new stake in shares of Welltower Inc. (NYSE:WELL – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,430 shares of the real estate investment trust’s stock, valued at approximately $116,000. Other institutional investors have also added to […]

Natixis purchased a new stake in Sealed Air Co. (NYSE:SEE – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,366 shares of the industrial products company’s stock, valued at approximately $95,000. Several other hedge funds also recently added to or […]

Natixis reduced its position in Mirati Therapeutics, Inc. (NASDAQ:MRTX – Free Report) by 89.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 3,500 shares of the biotechnology company’s stock after selling 28,209 shares during the period. Natixis’ holdings in Mirati Therapeutics were worth $126,000 at the end […]